Home › Physicians › Prof. Turgut Kaçan
Medical Oncology Specialist
Prof. Turgut Kaçan
He has made congress presentations on kidney and bladder cancers, immunotherapy applications and targeted treatments in medical oncology.
Doruk Private Nilüfer Hospital
Credentials
Medical School
2004 · Ege University Faculty of Medicine
Specialty Training
2014 · Internal Medicine and Medical Oncology
Born
1979 · YILDIZELİ
Practices at
Doruk Private Nilüfer Hospital
Credentials
Medical Oncology specialization (2014)
Credentials
Internal Medicine specialty
Credentials
Doctor of Medicine — Ege University Faculty of Medicine (2004)
Credentials
Participation as a speaker at national oncology congresses
Credentials
Specialization thesis: Plasma drug level and cytogenetic response in chronic myeloid leukemia
Prof. Dr. Turgut Kaçan graduated from Ege University Faculty of Medicine in 2004. He completed his Internal Medicine and Medical Oncology specialization in 2014.
He prepared his specialization thesis on the relationship between plasma drug levels and cytogenetic response in patients with chronic myeloid leukemia receiving imatinib treatment.
He has made presentations at national congresses on the use of immunotherapy and side effect management, targeted and preoperative treatment approaches in renal cell cancer, treatment sequencing in metastatic bladder cancer, prostate cancer management, molecular targets in breast cancer and pain palliation in cancer patients. He is currently working at Doruk Private Nilüfer Hospital.
Highlights
Immunotherapy and side effect management
He has presented at national congresses on the use of immunotherapy and side effect management.
Urogenital cancers
He made presentations on treatment approaches in kidney, bladder and prostate cancers.
Targeted therapies
He made a presentation on targeted therapy in renal cell cancer and molecular targets in breast cancer.
Multidisciplinary tumor council
He participated in multidisciplinary tumor council case discussions at national congresses.
Pain control in cancer
He gave a congress presentation on pain palliation in cancer patients.
Academic study
He prepared his specialty thesis on the relationship between plasma drug levels and cytogenetic response in chronic myeloid leukemia.
Educational articles
The place of immunotherapy in cancer treatment
Systemic treatment in kidney cancer
Pain management in cancer
Frequently asked questions
Can immunotherapy be applied to every cancer patient?
If I start using painkillers too early, will they be ineffective in the future?
What is the difference between targeted therapy and chemotherapy?
Why is the treatment decision taken by the council?